PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Abstract
Authors
Y Zhu J Bell C Daskalopoulou C Ivanescu R Lai C Arizmendi D Mapiye L Shi M.A. Munegowda D Verma S Khan